Cancer Letters
Volume 223, Issue 2 , Pages 203-209 , 8 June 2005

Polyethylene glycol reduces inflammation and aberrant crypt foci in carcinogen-initiated rats

  • Pernilla C. Karlsson

      Affiliations

    • Department of Medical Nutrition, Karolinska Institutet, Novum, S-141 86 Huddinge, Sweden
    • ,
  • Roisin Hughes

      Affiliations

    • Northern Ireland Centre for Diet and Health, School of Biomedical Sciences, University of Ulster, Northern Ireland, BT52 1SA, UK
    • ,
  • Joseph J. Rafter

      Affiliations

    • Department of Medical Nutrition, Karolinska Institutet, Novum, S-141 86 Huddinge, Sweden
    • ,
  • W. Robert Bruce

      Affiliations

    • Department of Nutritional Sciences, The University of Toronto, 150 College street, Toronto, Ont., Canada, M5S 3E2
    • Corresponding Author InformationCorresponding author. Tel.: +1 416 978 5425; fax: +1 416 978 5882.

Received 14 July 2004 ,Revised 16 October 2004 ,Accepted 19 October 2004.

References 

  1. Attar A, Lemann M, Ferguson A, Halphen M, Boutron MC, Flourie B, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut. 1999;44:226–230
  2. Biasco G, Brandi G, Paganelli GM, Rossini FP, Santucci R, Di Febo G, et al. Colorectal cancer in patients with ulcerative colitis. A prospective cohort study in Italy. Cancer. 1995;75:2045–2050
  3. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 1995;93:55–71
  4. Carroccio A, Iacono G, Cottone M, Di Prima L, Cartabellotta F, Cavataio F, et al. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin. Chem. 2003;49:861–867
  5. Corpet DE, Parnaud G. Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis. 1999;20:915–918
  6. Corpet DE, Parnaud G, Delverdier M, Peiffer G, Tache S. Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens. Cancer Res. 2000;60:3160–3164
  7. DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am. J. Gastroenterol. 2000;95:446–450
  8. Duizer E, Van der Wulp C, Versantvoort CH, Groten JP. Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells. J. Pharmacol. Exp. Ther. 1998;287:395–402
  9. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994;35:1590–1592
  10. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 1998;58:409–412
  11. Kristinsson J, Armbruster CH, Ugstad M, Kriwanek S, Nygaard K, Ton H, et al. Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics. Scand. J. Gastroenterol. 2001;36:202–207
  12. Kristinsson J, Nygaard K, Sundseth A, Aadland E, Fagerhol MK. Comparison of faecal and intestinal concentrations of granulocyte marker protein and localization of gastrointestinal tumours in rats. Scand. J. Gastroenterol. 2002;37:1029–1033
  13. Kristinsson J, Nygaard K, Sundseth A, Aadland E, Fagerhol MK. Comparison of faecal and intestinal concentrations of granulocyte marker protein and localization of gastrointestinal tumours in rats. Scand. J. Gastroenterol. 2002;37:1029–1033
  14. Kristinsson J, Roseth AG, Sundset A, Nygaard K, Loberg EM, Paulsen JE, et al. Granulocyte marker protein is increased in stools from rats with azoxymethane-induced colon cancer. Scand. J. Gastroenterol. 1999;34:1216–1223
  15. Kronborg O, Ugstad M, Fuglerud P, Johne B, Hardcastle J, Scholefield JH, et al. Faecal calprotectin levels in a high risk population for colorectal neoplasia. Gut. 2000;46:795–800
  16. Laboisse CL, Maoret JJ, Triadou N, Augeron C. Restoration by polyethylene glycol of characteristics of intestinal differentiation in subpopulations of the human colonic adenocarcinoma cell line HT29. Cancer Res. 1988;48:2498–2504
  17. Lindmark T, Kimura Y, Artursson P. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J. Pharmacol. Exp. Ther. 1998;284:362–369
  18. Ma TY, Hollander D, Bhalla D, Nguyen H, Krugliak P. IEC-18, a nontransformed small intestinal cell line for studying epithelial permeability. J. Lab. Clin. Med. 1992;120:329–341
  19. Naigamwalla D, Chia MC, Tran TT, Medline A, Hay K, Gallinger S, et al. Polyethylene glycol 8000 and colon carcinogenesis: inhibition in the F344 rat, promotion in the Min mouse. Cancer Res. 2000;60:6856–6858
  20. Parnaud G, Corpet DE, Gamet-Payrastre L. Cytostatic effect of polyethylene glycol on human colonic adenocarcinoma cells. Int. J. Cancer. 2001;92:63–69
  21. Parnaud G, Tache S, Peiffer G, Corpet DE. Pluronic F68 block polymer, a very potent suppressor of carcinogenesis in the colon of rats and mice. Br. J. Cancer. 2001;84:90–93
  22. Parnaud G, Tache S, Peiffer G, Corpet DE. Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats. Cancer Res. 1999;59:5143–5147
  23. Pool-Zobel B, Van Loo J, Rowland I, Roberfroid MB. Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. Br. J. Nutr. 2002;87(Suppl. 2):S273–S281
  24. Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 2004;13:279–284
  25. Pretlow TP, O'Riordan MA, Somich GA, Amini SB, Pretlow TG. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis. 1992;13:1509–1512
  26. Roy HK, DiBaise JK, Black J, Karolski WJ, Ratashak A, Ansari S. Polyethylene glycol induces apoptosis in HT-29 cells: potential mechanism for chemoprevention of colon cancer. Fed. Eur. Biochem. Soc. Lett. 2001;496:143–146
  27. Roy HK, Gulizia J, DiBaise JK, Karolski WJ, Ansari S, Madugula M, et al. Polyethylene glycol inhibits intestinal neoplasia and induces epithelial apoptosis in Apc(min) mice. Cancer Lett. 2004;215:35–42
  28. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis. 1999;20:1425–1431
  29. Summerton CB, Longlands MG, Wiener K, Shreeve DR. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur. J. Gastroenterol. Hepatol. 2002;14:841–845
  30. Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000;47:506–513
  31. Voytik-Harbin SL, Brightman AO, Waisner B, Lamar CH, Badylak SF. Application and evaluation of the alamarBlue assay for cell growth and survival of fibroblasts. In Vitro Cell Dev. Biol. Anim. 1998;34:239–246
  32. Wali RK, Koetsier JL, Bissonnette M, Roy H. Polyethylene glycol (PEG) suppresses transcription factor SNAIL in AOM-induced colonic aberrant crypt foci (ACF) and human colon. Gastroenterology. 2003;124:A-604
  33. Wali RK, Stoiber JA, Hart TA, Brasitus M, Bissonnette U. Polyethylene glycol supresses hyperproliferation and increases apoptosis in AOM-induced colonic aberrant cryps. Gastroenerology. 2002;122:A-241

PII: S0304-3835(04)00840-7

doi: 10.1016/j.canlet.2004.10.029

Cancer Letters
Volume 223, Issue 2 , Pages 203-209 , 8 June 2005

Article Tools

* Image Usage & Resolution